IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)          Journal is Currently Not Indexed in Scopus as on february 2021 list provided by scopus

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
“Stability Indicating RP-HPLC Method Development and Validation for the Estimation of Remogliflozin Etabonate in Bulk and Pharmaceutical Dosage Form”

Author: TUSHAR BHATKAR, AMOL V. BADKHAL, NITIN S. BHAJIPALE
Abstract: A simple, fast, and highly selective RP-HPLC method was developed for the determination of remogliflozin etabonate in API and tablet dosage form. The separation was done by using Agilent technology HPLC. Column Agilent C18 (250mm × 4.6 mm) with Mobile Phase was Methanol : 0.1% Ortho phosphoric acid (80:20% v/v). The flow rate was 0.9ml/min, and the analytes were measured at ?max 227 nm. The retention time for remogliflozin etabonate was 4.881 min, respectively. The method was validated with respect to system suitability, linearity, precision, accuracy, specificity, limit of detection (LOD), limit of quantification (LOQ), robustness and ruggedness. Linearity studies was performed (10–60µg/ml), LOD and LOQ was found to be 0.2201 and 0.6669 µg/ml respectively. The relative standard deviation for accuracy was found to be less than 2 %. The mean percentage recovery was 99.50% to 100.12 %.The forced degradation studies were carried out by using 0.01N NaOH, 1.0 N HCl, 3 % H2O2. Deprivation performance shows that the major deprivation was observed at basic condition i.e. NaOH (5.06 %) followed by HCl (4.71%), H2O2 (4.04%) and Thermal (5.45) respectively.
Keyword: Remogliflozin etabonate, Methanol, RP-HPLC, Method development, Validation, Forced degradation.
DOI: https://doi.org/10.31838/ijpr/2020.12.04.026
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free